Skip to content
Use caution Drug recall · FDA · Published September 5, 2017

Aidarex Recalls Phentermine 15mg Capsules Due to Impurity Issues

Aidarex Pharmaceuticals recalls specific lots of 15mg Phentermine capsules due to failed impurity specifications. Check your bottle's batch number and expiration date.

🇺🇸 FDA recall #D-1162-2017DrugAidarex Pharmaceuticals ›
Take action

Contact the company

Recalling firmAidarex Pharmaceuticals LLC595 N Smith Ave Ste B · Corona, CA 92880-6920
✎ GovInfoNow plain-language explainer

What happened, in plain English

Aidarex Pharmaceuticals LLC is recalling Phentermine, USP Capsules, 15 mg in 30-count bottles because they contain out-of-specification unknown impurities. The issue was identified during a stability test for the 30-month room temperature retained sample. This recall affects specific batches distributed to California and Nevada. Read more at govinfonow.com/recall/41260-aidarex-recalls-phentermine-15mg-capsules-due-to-impurity-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/41260-aidarex-recalls-phentermine-15mg-capsules-due-to-impurity-issues · Updated October 11, 2026 · FDA enforcement record: FDA #D-1162-2017

Cite this page

“Aidarex Recalls Phentermine 15mg Capsules Due to Impurity Issues.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41260-aidarex-recalls-phentermine-15mg-capsules-due-to-impurity-issues. Based on FDA recall #D-1162-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1162-2017%22&limit=1).

Why it’s dangerous

The recalled capsules failed impurity specifications, meaning they contain unknown impurities above the allowed limits. While the record does not specify the exact health effects of these impurities, failing pharmaceutical purity standards means the drug's safety and efficacy cannot be guaranteed as intended.

Who’s affected

Individuals who purchased Phentermine, USP Capsules, 15 mg from pharmacies in California or Nevada between the manufacturing dates and expiration dates listed below are likely affected. Patients relying on these specific batches for weight management may be at risk of receiving medication that does not meet purity standards.

How to tell if you have this one

Check your bottle for the brand Aidarex Pharmaceuticals and the product name Phentermine, USP Capsules, 15 mg. Look for the following specific batch numbers: 47262-2 (exp 8/31/2017), 47262-4 (exp 12/30/17), and 47262-5, 47262-6, 47262-7 (exp 12/31/17). The product was distributed to California and Nevada.

  • Brand
    Aidarex Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Reach out to the pharmacy where you purchased the medication to discuss your specific situation and potential replacement options.

  2. Verify Batch Numbers

    Check your bottle against the recalled batch numbers (47262-2, 47262-4, 47262-5, 47262-6, 47262-7) to confirm if you have the affected product.

Where it went and when

Where it was distributed

Distributed in California and Nevada.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: yesNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed to the state of CA and NV.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Nevada.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Sep 5, 201712. FDA classified it Class III: Sep 13, 201723. Published in FDA’s Enforcement Report: Sep 20, 201734. FDA terminated the recall: Dec 4, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1162-2017 (September 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1162-2017 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA